Our Services
Sponsor demand increases by the day.
The executive order prioritizes psychedelic research.
Sponsors are searching for qualified sites.
Sites that prove feasibility now reach the front of the line.
We get you there.
Clinical Trial and Regulatory Roadmaps
Guidance on navigating the complex regulatory landscape for neuropsychiatric medicines, including:
Pre-IND consultations
IND preparation
Clinical development plan design
Phase I, II, and III clinical trial design
Commercialization & post-marketing strategy
Business Strategy and Market Research
Support for businesses entering the neuropsychiatric and psychedelic medicine space, including:
Market analysis
Competitive intelligence
Business model development
Partnership strategies
Fundraising guidance
Regulatory compliance for scheduled drug storage
Clinical Guidance and Healthcare Integration
Development of frameworks and clinical protocols for the integration of psychedelic therapies into clinical practice, addressing:
Patient safety
Informed consent
Therapist training
Equitable access
Culturally-relevant messaging for Healthcare Professionals
Let’s Connect
Ready to accelerate your psychiatric drug development?
Let's talk. Tell us more about your R&D goals, challenges, and questions.